StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health consolidated Operating Expense (SG&A — GAAP) ($M)

Quarterly figures from Elevance Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
5,752
Period ended Sep 30, 2026
Change on a year earlier
+9.1%
5,272 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated Operating Expense (SG&A — GAAP) ($M)Year on yearSource
Q3 2026Sep 30, 20265,752+9.1%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q2 2026Jun 30, 20265,547+11.0%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q1 2026Mar 31, 20266,330+19.4%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q4 2025Dec 31, 20255,415+12.7%ELV 10-K (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q3 2025Sep 30, 20255,272+0.1%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q2 2025Jun 30, 20254,997-1.4%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q1 2025Mar 31, 20255,300+8.5%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q4 2024Dec 31, 20244,804-3.9%ELV 10-K (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q3 2024Sep 30, 20245,269-3.7%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q2 2024Jun 30, 20245,066+5.1%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q1 2024Mar 31, 20244,886+1.8%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q4 2023Dec 31, 20234,999+9.5%ELV 10-K (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q3 2023Sep 30, 20235,470+21.1%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q2 2023Jun 30, 20234,818+12.8%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q1 2023Mar 31, 20234,800+10.5%ELV 10-Q (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗
Q4 2022Dec 31, 20224,567+8.1%ELV 10-K (XBRL us-gaap:SellingGeneralAndAdministrativeExpense) ↗

Breakdown

What makes up consolidated operating expense (sg&a — gaap)

Cite this data

StockData. (2026). Elevance Health Consolidated Operating Expense (SG&A — GAAP) ($M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/fin_operating_expense_gaap

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.